AstraZeneca antibody cocktail fails to prevent COVID-19 symptoms in trial

AstraZeneca antibody cocktail fails to prevent COVID-19 symptoms in trial

AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms in trial participants recently exposed to the virus, the company announced Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *